Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramEvery ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 29 | Doyle MittieChief Medical Officer | Open-market sale · 10b5-1 plan | SELL | $426K 19.0K sh | May 7, 2026 |
| 29 | Doyle MittieChief Medical Officer | Open-market sale · 10b5-1 plan | SELL | $953K 44.9K sh | May 7, 2026 traded May 6, 2026 |
| 28 | Robin Jodi F.General Counsel and Secretary | Open-market sale | SELL | $123K 3,000 sh | May 7, 2026 traded May 5, 2026 |
| 28 | Jaime CesarDirector | Open-market sale | SELL | $123K 10.0K sh | May 7, 2026 traded May 5, 2026 |
| 27 | David J. TaylorRSelf | Sale | SELL | $1,001 – $15K | May 7, 2026 traded Apr 27, 2026 |
| 26 | Doyle MittieChief Medical Officer | Open-market sale · 10b5-1 plan | SELL | $230K 10.1K sh | May 7, 2026 traded May 6, 2026 |
| 26 | Sullivan Christopher RyanChief Financial Officer | Open-market sale · 10b5-1 plan | SELL | $201K 8,900 sh | May 7, 2026 traded May 6, 2026 |
| 26 | Eldessouky SamEVP and CFO | Tax withholding | F | $1.02M 63.9K sh | May 7, 2026 traded May 5, 2026 |
| 26 | Gallagher Thomas P.Director, Chairman & CEO | Open-market sale · 10b5-1 plan | SELL | $756K 15.8K sh | May 7, 2026 traded May 5, 2026 |
| 25 | Doyle MittieChief Medical Officer | Open-market sale · 10b5-1 plan | SELL | $496K 27.5K sh | May 7, 2026 traded May 6, 2026 |
| 25 | Sullivan Christopher RyanChief Financial Officer | Open-market sale · 10b5-1 plan | SELL | $257K 13.8K sh | May 7, 2026 traded May 6, 2026 |
| 25 | Neagle MatthewChief Operating Officer | Open-market sale | SELL | $634K 60.8K sh | May 7, 2026 traded May 5, 2026 |
| 24 | Greg StantonDSpouse | Partial sale | SELL | $15K – $50K | May 7, 2026 traded May 6, 2026 |
| 24 | Robin Jodi F.General Counsel and Secretary | Open-market sale | SELL | $83K 2,000 sh | May 7, 2026 traded May 7, 2026 |
| 23 | Enguent Jean-PierreVice President, R&DSS | Open-market sale · 10b5-1 plan | SELL | $47K 15.0K sh | May 7, 2026 traded May 6, 2026 |
| 22 | Bruggeworth Robert ADirector, President and CEO | Tax withholding | F | $1.63M 17.6K sh | May 7, 2026 traded May 5, 2026 |
| 22 | Canup Edward GCHIEF BANKING OFFICER | Open-market purchase | BUY | $20K 1,000 sh | May 7, 2026 traded May 5, 2026 |
| 22 | Guggina David WExecutive Vice President | Tax withholding | F | $1.21M 9,247 sh | May 7, 2026 traded May 5, 2026 |
| 22 | Sullivan Christopher RyanChief Financial Officer | Open-market sale · 10b5-1 plan | SELL | $197K 9,219 sh | May 7, 2026 traded May 6, 2026 |
| 22 | Sullivan Christopher RyanChief Financial Officer | Open-market sale · 10b5-1 plan | SELL | $238K 12.3K sh | May 7, 2026 traded May 6, 2026 |
| 22 | Tabak ShawnCHIEF FINANCIAL OFFICER | Open-market sale | SELL | $111K 10.6K sh | May 7, 2026 traded May 5, 2026 |
| 21 | Heller John E.Director, Chief Executive Officer | Option exercise | M | — 18.1K sh | May 7, 2026 traded May 6, 2026 |
| 21 | Hunt Bradley WilliamDirector | Grant or award | A | — 20.8K sh | May 7, 2026 traded May 5, 2026 |
| 21 | Jones RamonDirector | Grant or award | A | — 20.8K sh | May 7, 2026 traded May 5, 2026 |
| 21 | Rodriguez Robles Yaiza MariaGC & Secretary of the BOD | Grant or award | A | — 7,000 sh | May 7, 2026 traded May 5, 2026 |
| 21 | Priebe DavidDirector | Grant or award | A | — 4,929 sh | May 7, 2026 traded May 5, 2026 |
| 21 | Mullen Sean ThomasChief Growth Officer | Option exercise | M | — 9,072 sh | May 7, 2026 traded May 6, 2026 |
| 21 | Bruning Jill LChief Technology Officer | Option exercise | M | — 9,072 sh | May 7, 2026 traded May 6, 2026 |
| 21 | Natan DavidDirector | Grant or award | A | — 100.0K sh | May 7, 2026 traded May 5, 2026 |
| 21 | Sher AvivChief Executive Officer | Grant or award | A | — 30.0K sh | May 7, 2026 traded May 5, 2026 |
| 21 | Hagy James BrentChief Legal Officer&CorpSec(1) | Grant or award | A | — 1,850 sh | May 7, 2026 traded May 5, 2026 |
| 21 | Guivisdalsky Deborah FridaChief Operating Officer | Grant or award | A | — 7,000 sh | May 7, 2026 traded May 5, 2026 |
| 21 | Viana Antonio JDirector | Open-market sale · 10b5-1 plan | SELL | $601K 20.0K sh | May 7, 2026 traded May 5, 2026 |
| 21 | Zamudio-Ramirez PavelChief Customer Officer | Option exercise | M | — 2,935 sh | May 7, 2026 traded May 5, 2026 |
| 20 | David J. TaylorRSelf | Purchase | BUY | $1,001 – $15K | May 7, 2026 traded Apr 27, 2026 |
| 20 | David J. TaylorRSelf | Purchase | BUY | $1,001 – $15K | May 7, 2026 traded Apr 27, 2026 |
| 20 | David J. TaylorRSelf | Purchase | BUY | $1,001 – $15K | May 7, 2026 traded Apr 27, 2026 |
| 20 | David J. TaylorRSelf | Purchase | BUY | $1,001 – $15K | May 7, 2026 traded Apr 27, 2026 |
| 19 | Sawhney InderpreetChief Legal Officer | Grant or award | A | — 4,880 sh | May 7, 2026 traded Mar 31, 2026 |
| 19 | Doyle MittieChief Medical Officer | Open-market sale · 10b5-1 plan | SELL | $27K 1,679 sh | May 7, 2026 traded May 5, 2026 |